Skip to content
MarketScale
‹ Back to IndustriesHealthcare

A Military Veteran’s Advice on Leadership in Healthcare? Build Leader Resiliency to Reduce Burnout

The future of healthcare leadership is a conversation that’s becoming increasingly crucial. The healthcare industry faces unprecedented challenges in the wake of the ongoing COVID-19 pandemic. It’s a time when leadership needs to be reimagined, particularly in an industry where burnout and compassion fatigue are rife among front-line workers. Estimates indicate 60% of healthcare…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Holistic Leadership on MarketScale.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

The future of healthcare leadership is a conversation that’s becoming increasingly crucial. The healthcare industry faces unprecedented challenges in the wake of the ongoing COVID-19 pandemic. It’s a time when leadership needs to be reimagined, particularly in an industry where burnout and compassion fatigue are rife among front-line workers. Estimates indicate 60% of healthcare workers reported burnout during the height of the pandemic. This fatigue continues to cause healthcare workers to leave the field, creating a gap in an industry whose needs are growing, not shrinking.

Considering these staggering figures, how can leadership in healthcare evolve to combat these challenges, foster resilience, and adapt to the changing landscape of this crucial sector?

In the latest episode of Holistic Leadership, The Future of Work & Education in Healthcare, hosted by Travis Hearne, we dive into this pertinent discussion with Dr. Kathleen Flarity, a veteran healthcare and military leader with more than four decades of service.

In this episode, the conversation revolves around three main areas:

  • The link between healthcare provider resiliency and leader resiliency and how fostering these can mitigate the risks of burnout and compassion fatigue
  • The balance between individual responsibility and organizational responsibility in healthcare leadership, particularly in the context of addressing systemic burnout
  • The evolution of Dr. Flarity’s mission and calling for leaders in the healthcare space, informed by her unique experiences in both healthcare and the military

Dr. Kathleen Flarity is a highly decorated military veteran, an esteemed academic, and a pioneer in healthcare. Her esteemed career includes serving as Deputy Director of the University of Colorado Anschutz Center for Combat Medicine and Battlefield Research and the role of Air Force Brigadier General.

Beyond her military service, Dr. Flarity has published over 16 book chapters and 32 journal articles, including 15 peer-reviewed research manuscripts. She has significantly contributed to the healthcare field as an associate clinical professor of emergency medicine at the University of Colorado Denver Anschutz Medical Campus and the President of the Aerospace Nursing and Allied Health Professional Society.

She is also the president and founder of Flarity Consulting LLC, specializing in leadership consulting and re-engineering clinical processes. Her unique insights and experiences make her an authoritative voice in the evolving discussion around healthcare leadership.

Holistic Leadership

Part of this channel

Holistic Leadership

Healthcare leadership grounded in culture, well-being, and practical growth.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 is focusing on integrating smart glasses and AI into the purchasing processes for optical retailers and labs. The event is anticipated to attract around 34,000 visitors and feature 950 exhibitors, indicating significant interest in AI imaging workflows and smart-glass innovations. The agenda highlights a future direction towards advanced technology in optical retail and laboratory settings.

  • 01SILMO Paris 2026 will host nearly 34,000 visitors and 950 exhibitors.
  • 02The event focuses on AI imaging workflows and smart-glass innovations for optical retailers and labs.
  • 03Significant interest is shown in integrating advanced technology within optical retail processes.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512